Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 Credit Suisse Global Healthcare Conference
November 05, 2014 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development, Regulatory Affairs
October 23, 2014 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced three executive appointments that expand and...
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
October 21, 2014 18:00 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., October 21, 2014 and OSAKA, Japan, October 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, and Takeda...
Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With Takeda
October 14, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it signed on October 9, 2014 an...
Clinical Data for AMITIZA(R) Lubiprostone to be Presented at the American College of Gastroenterology 2014 Annual Scientific Meeting
October 13, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 13, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for AMITIZA®...
Sucampo Announces Settlement Agreement That Resolves Patent Litigation in U.S. Related to AMITIZA
October 09, 2014 16:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd. (RTU), Takeda...
Sucampo Announces Departure of Chief Financial Officer
October 06, 2014 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Cary J. Claiborne, Chief Financial...
Sucampo and Takeda Launch Direct-to-Consumer Advertising Campaign for AMITIZA(R) (lubiprostone) for Chronic Idiopathic Constipation
September 29, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) and its development and commercialization partner, Takeda Pharmaceuticals (Takeda), today...
Sucampo Reports Second Quarter 2014 Financial Results and Corporate Update
August 05, 2014 06:15 ET
|
Sucampo Pharmaceuticals Inc
Positive Net Income Driven by Strong Revenue Growth in Product Royalty and Product Sales
CEO Peter Greenleaf to Discuss Results of Sucampo's Strategic Review
Company Raises Full Year 2014...
Sucampo Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone)
July 23, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Maryland and ABINGDON, Oxfordshire, July 23, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the...